Back

Understanding non-prescription of guideline-directed medical therapy in acute heart failure and advanced kidney disease: a nation-wide study

9 May 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Treatment and prevention of acute heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Inga Jona Ingimarsdottir

Landspitali University Hospital, Reykjavik (Iceland)

5 More presentations in this session

Presentation thumbnail
Early effects of SGLT2 inhibitors in acute heart failure: an individual patient level meta-analysis
Doctor L. Zonneveld (Groningen, NL)
Abstract Slides
Presentation thumbnail
Hemodynamic effects of nitroglycerin-induced vasodilation in acute heart failure
Doctor J. Lukoschewitz (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
VECTOR-HF II: Preliminary insights on physician-directed patient self-management in HF
Doctor M. Del Trigo (Majadahonda, ES)
Abstract Slides
Presentation thumbnail
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in patients with moderate or severe aortic stenosis and acute heart failure: data from a prospective cohort study
Doctor D. Kosmidis (Drama, GR)
Abstract Slides
Presentation thumbnail
Usefulness of the TRIAGE-HF Plus system for the remote monitoring of patients with heart failure
Doctor D. Enriquez Vazquez (A Coruna, ES)
Abstract Slides

Access the full session

Session thumbnail
Treatment and prevention of acute heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 10:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources